Trials / Conditions / Benign Prostatic Hypertrophy

Benign Prostatic Hypertrophy

25 registered clinical trials studyying Benign Prostatic Hypertrophy.

Status	Trial	Sponsor	Phase
Active Not Recruiting	Outpatient Holmium LASER Enucleation of the Prostate: Benefit of MOSES(TM) 2.0 Technology NCT05768776	University Hospital, Bordeaux	—
Completed	Wolf 24 F vs. Storz 28 F Laser Sheath Size for HoLEP NCT05308017	Northwestern University	N/A
Completed	Tranexamic Acid to Improve Same-day Discharge Rates After Holmium Laser Enucleation of the Prostate (HoLEP) NCT05082142	Northwestern University	Phase 4
Completed	Transperineal Laser Ablation vs Transurethral Resection for Benign Prostatic Obstruction: A Randomized Clinica NCT04781049	San Carlo di Nancy Hospital	N/A
Terminated	Transurethral Vapor Enucleation Resection of the Prostate (TVERP), Bipolar TURis and HoLEP NCT04398420	Olympus Surgical Technologies Europe	N/A
Suspended	Comparison of Different Energy Sources During TUR-P NCT02533687	Selcuk University	N/A
Unknown	Evaluation of the NV-VPAC1 Prostate Cancer (PCa) Urine Diagnostic Test in Subjects With Biopsy-confirmed Prost NCT03630926	Intermountain Health Care, Inc.	—
Completed	Optilume™ BPH Prostatic Drug Coated Balloon Dilation Catheter NCT03423979	Urotronic Inc.	Phase 2
Terminated	Prostate Embolization for Massive Benign Prostatic Hypertrophy (BPH) NCT02676544	Rhode Island Hospital	Phase 1 / Phase 2
Completed	Safety and Efficacy of OCL 503 in Prostate Artery Embolization NCT02509975	IMBiotechnologies Ltd.	N/A
Completed	Feasibility Study of Photovaporisation of Prostate With a Limitated Length of Catheterization of 3 Hours NCT02401581	Centre Hospitalier Universitaire de Nice	N/A
Completed	Moxibustion as an Adjuvant for Benign Prostatic Hyperplasia With Lower Urinary Tract Symptoms: a Pilot Study NCT02051036	JUNGNAM KWON	N/A
Completed	Saline With Alcohol in TransUrethral Resection aNd Photoselective Vaporisation of the Prostate NCT02429219	University of Magdeburg	N/A
Completed	The Effects of Intrathecal Dexmedetomidine on Spinal Anesthesia Using Diluted Low-Dose Bupivacaine for Transur NCT01342562	Yonsei University	N/A
Completed	Safety and Efficacy of QD Versus BID Silodosin With Lower Urinary Tract Symptoms Suggestive of BPH NCT01260129	JW Pharmaceutical	Phase 4
Completed	Prostate Cancer Antigen 3 (PCA-3) Gene Project NCT01177436	Assistance Publique Hopitaux De Marseille	N/A
Completed	Solifenacin as Add-on Therapy for Overactive Bladder Symptoms in Men Treated for Benign Prostatic Hyperplasia NCT00771394	Astellas Pharma Inc	Phase 4
Completed	Cetrorelix Pamoate in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH) NCT00663858	AEterna Zentaris	Phase 3
Completed	Cetrorelix Pamoate IM Regimens in Patients With Symptomatic Benign Prostatic Hyperplasia (BPH) NCT00670306	AEterna Zentaris	Phase 3
Completed	Integrating Targeted MedlinePlus Health Prescriptions Into Clinic Practice Workflow NCT00634608	University of Missouri-Columbia	N/A
Terminated	Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH) NCT00449150	AEterna Zentaris	Phase 3
Completed	The Safety and Efficacy of Ozarelix to Treat Men With Lower Urinary Tract Symptoms Due to Enlargement of the P NCT00427219	Spectrum Pharmaceuticals, Inc	Phase 2
Completed	Dutasteride After Failure of Finasteride In the Management of Symptomatic Prostatic Enlargement/Hypertrophy (B NCT00382356	North Florida/South Georgia Veterans Health System	N/A
Completed	Safety/Tolerability Study of Alcohol Injection for Treatment of BPH (Enlarged Prostate) NCT00037141	American Medical Systems	Phase 1 / Phase 2
Completed	Clinical Trial in Males With BPH (Enlarged Prostate) NCT00029822	Sanofi	Phase 3